Skip to content
DataLookout
Menu

NCT07895667

Adjunctive Diode Laser Therapy for Peri-Implant Mucositis

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in Bleeding on Probing (BOP)
Timeframe: Baseline, 4-6 weeks, 3 months, 6 months, and 12 months

Secondary (4)

Change in Probing Depth (PD)
Change in Plaque Index (PI)
Change in Peri-Implant Crevicular Fluid (PICF) Volume
Change in Matrix Metalloproteinase-8 (MMP-8) Levels

Arms and interventions

Control GroupActive comparator

Participants allocated to the control group will receive conventional non-surgical treatment for peri-implant mucositis consisting of mechanical debridement of the peri-implant surface, followed by irrigation of the peri-implant sulcus with 0.12% chlorhexidine and 0.05% cetylpyridinium chloride. Participants will also receive individualized oral hygiene instructions.

Diode Laser GroupExperimental

Participants allocated to the test group will receive conventional non-surgical treatment for peri-implant mucositis combined with adjunctive high- and low-intensity photothermal diode laser therapy.

Procedures: Conventional Non-Surgical Treatment

Devices: FOX III Diode Laser Therapy